The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.
NYLI Healthy Hearts ETF HART
Morningstar’s Analysis HART
Will HART outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 48.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Pfizer Inc | 5.05 | 458,132 | Healthcare |
Alphabet Inc Class A | 5.04 | 456,946 | Communication Services |
Abbott Laboratories | 5.03 | 456,556 | Healthcare |
Apple Inc | 5.02 | 455,723 | Technology |
UnitedHealth Group Inc | 4.92 | 446,627 | Healthcare |
Johnson & Johnson | 4.92 | 446,405 | Healthcare |
Novartis AG Registered Shares | 4.85 | 440,322 | Healthcare |
Eli Lilly and Co | 4.79 | 434,655 | Healthcare |
AstraZeneca PLC | 4.55 | 412,975 | Healthcare |
Novo Nordisk AS Class B | 4.54 | 411,903 | Healthcare |